Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma (GIPI)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
University of California, San Francisco
Information provided by (Responsible Party):
Lynn E. Spitler, MD, Northern California Melanoma Center
ClinicalTrials.gov Identifier:
NCT01363206
First received: May 27, 2011
Last updated: March 6, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2015
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)